Pharmaceutical Lipids Market
Number of pages: 100 | Report Format: PDF | Published date: January 17, 2023
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
|
Report Attribute |
Details |
|
Market Size Value in 2021 |
US$ 5.84 billion |
|
Revenue forecast in 2030 |
US$ 10.41 billion |
|
CAGR |
6.64% |
|
Base Year for Estimation |
2021 |
|
Forecast period |
2022-2030 |
|
Historical Year |
2020 |
|
Segments Covered |
Product, Source, Form, Application, End-user and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, and the Rest of the World (RoW) |
According to the deep-dive market assessment study by Growth Plus Reports, the global pharmaceutical lipids market was valued at US$ 5.84 billion in 2021 and is expected to register a revenue CAGR of 6.64 % to reach US$ 10.41 billion in 2030.
Pharmaceutical Lipids Market Fundamentals
Lipids are organic compounds that are insoluble in water. Fats and oils are common names for lipids. Oils are liquid at room temperature, whereas fats remain solid. One of the most crucial elements of both natural foods and several manufactured chemicals & emulsions is lipids. The components of bioactive lipids depend on their contribution to health. Lipids are only soluble in an organic, non-polar solvent. These molecules, which are present in meals, such as oil, butter, whole milk, cheese, fried dishes, and some red meats, can be secreted by the liver in the human body. Triacylglycerols are the most prevalent (TAGs) lipids. In the pharmaceutical industry, lipids are frequently utilized as fillers, binders, lubricants, solubilizers, emulsifiers, and emollients.
[4545454]
Pharmaceutical Lipids Market Dynamics
The global pharmaceutical lipids market is expected to gain significant revenue growth opportunities during the forecast period owing to growing cosmetic industry and rising demand for lipid solutions as ingredients from the beauty industry. Major market players are increasing investments in product development activities and adopting the strategy of growing their businesses through product launches and acquisitions. Such initiatives, in turn, are expected to accelerate revenue growth in the pharmaceutical lipids market in the next few years.
However, rising prices of fatty acid and other raw materials is likely to hinder revenue growth of the global pharmaceutical lipids market during the forecast period.
Pharmaceutical Lipids Market Ecosystem
The global pharmaceutical lipids market is analyzed based on six parameters: product, source, form, application, end user, and region.
Pharmaceutical Lipids Market by Product
[2345424]
Based on the product, the global pharmaceutical lipids market is segmented into triglycerides, phospholipids, sphingolipids, cholesterol, fatty acids, and others.
The triglycerides segment accounts for the largest revenue of the global market. Its large revenue share can be attributed to rising demand for medium-chain triglycerides, and long-chain triglycerides to be used in efficient beverages and dietary supplements, for their derivatives. Since triglyceride lipids constitute a significant source of energy, they are widely used in a variety of functional foods and beverages. They can be utilized in many galenic forms, such as a basis for suppositories, solubilizers, emulsifiers, substrates or lubricants in tablets, and soft gel capsules. Thus, various industrial applications of triglyceride products are fueling revenue growth in the segment.
Pharmaceutical Lipids Market by Source
Based on the source, the global pharmaceutical lipids market is segmented into synthetic, semi-synthetic, and natural sources.
The semi-synthetic segment accounts for the largest revenue share of the global market. Fundamentally, there are two sources of lipids, natural and synthetic. Natural sources are considered not suitable for clinical purposes due to stability issues and to avoid potential viral or protein contamination. Glycerol or glycerol-3-phosphocholine (GPC) produced from a plant or animal source can be used to develop synthetic lipids. Since a portion of the molecule comes from a natural source, the latter is occasionally referred to as semi-synthetic lipid. On the other hand, animal-derived products do not have any advantages over synthetic lipids, despite the regulatory concerns. These are intrinsically less stable, and the synthetic alternative typically costs the same as or less than the product obtained from tissue. Semi-synthetic polymers are frequently used in cosmetic products, such as creams, shampoos, lotions, and gels as gelling agents, bioadhesives, thickening, and stabilizing agents. Compared to natural gelling agents, they are less susceptible to microbial contamination. Thus, the expanding cosmetic industry is also contributing to the revenue growth in the segment.
Pharmaceutical Lipids Market by Form
In terms of the form, the global pharmaceutical lipids market is segmented into liquid, semi-solid, and solid.
The semi-solid lipid segment accounts for the largest revenue share of the market. This can be ascribed to semi-solid lipid’s semi-solid texture and colloidal particle size, which are the most recent generation of lipid nanoparticles acting as potential systems in nano-cosmeceuticals. Furthermore, as semi-solid consistency can be achieved in a single stage, it makes production simpler and eliminates the need for additional excipients. Additionally, it has been observed that despite the high lipid content, a gel-like structure can be formed while the semi-solid solution maintains the colloidal size and viscoelastic capabilities. Hence, with easy accessibility, simpler production process, and advantages over liquid and solid lipids, the global market of semi-solid lipids is expected to expand at higher revenue CAGR in the upcoming few years.
Pharmaceutical Lipids Market by Application
Based on the application, the global pharmaceutical lipids market is segmented into conventional lipid-based drug delivery systems, self-emulsifying drug delivery systems, self-micro-emulsifying drug delivery systems, liposomes, solid lipid nanoparticles, nanostructured lipid carriers, and others.
The conventional lipid-based drug delivery system segment dominates the market with the largest revenue share. The primary objective of this formulation is to enhance the bioavailability of lipid-based medicines. One of the innovative technologies created to solve issues, such as solubility and bioavailability of poorly water-soluble pharmaceuticals, is lipid-based drug delivery systems. Lipid-based formulations can be customized to satisfy a variety of product needs, including those imposed by the indication of a condition, the method of administration, cost considerations, product stability, toxicity, and efficacy. It is a smart marketing strategy to use these formulations to produce drugs for topical, oral, pulmonary, or parenteral administration. Additionally, it has been demonstrated that lipid-based formulations can alter the biodistribution of a drug's toxicity by shifting it away from sensitive organs.
Pharmaceutical Lipids Market by End user
Based on the end user, the global pharmaceutical lipids market is segmented into biopharmaceutical companies, contract research organizations, academics, and research institutes.
The biopharmaceutical companies segment accounts for the largest revenue share of the market. Expanding usage of lipids in drug development and numerous other pharmaceutical applications is expected to drive revenue growth in the global market during the forecast period. This segment was one of the most essential components used in the discovery of COVID-19 vaccines in 2021. In the pharmaceutical business, these lipids are recognized as an essential excipient to create a vast majority of dosage forms. Rising health concerns and increasing awareness about the importance of medications are expected to fuel the demand for pharmaceuticals, driving revenue growth in the biopharmaceutical companies segment.
Pharmaceutical Lipids Market by Region
Based on the region, the global pharmaceutical lipids market is expanded across North America, Europe, Asia Pacific, and the Rest of the World (RoW).
North America accounts for the largest revenue CAGR of the global market owing to increase in understanding about severe precautions and consumption of immune-boosting foods among the regional population. As a result, functional foods and dietary supplements are considered integral part of daily diets in North America. Rising consumption of dietary supplements and functional food is expected to fuel revenue growth in the North America market.
Pharmaceutical Lipids Market Competitive Landscape
The prominent players operating the global pharmaceutical lipids market are:
Pharmaceutical Lipids Market Strategic Development
Two of the most common lipids used in the pharmaceutical industry are triglycerides and cholesterol. In the pharmaceutical industry, lipids and polymers are regarded as essential excipients to produce numerous prescription drugs. They take on many different functions, including those of solubilizers, transfection agents, stabilizers, permeation enhancers, and others.
Flourishing cosmetic industry and rising usage of lipid solutions as an ingredient in the beauty industry are propelling the global market revenue growth.
ABITEC Corporation (ABF Ingredients), BASF SE, Croda International Plc, CordenPharma, and NOF (Nippon Oil & Fats) Corporation are among the leading players in the global market.
Rising costs of fatty acids and other raw materials are hindering revenue growth of the global pharmaceutical lipids market.
The global pharmaceutical lipids market is expected to register a revenue CAGR of 6.64% during the forecast period.
*Insights on financial performance are subject to the availability of information in the public domain